Treosulfan Recruiting Phase 2 Trials for Squamous Cell Carcinoma of Lung / Non-Small Cell Lung Carcinoma (NSCLC) / Non-squamous Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02852083A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC